This case highlights that <sup>18</sup>F-PSMA PET/CT may reveal rare, intensely PSMA-avid non-prostatic neoplasms and underscores the importance of recognizing atypical uptake patterns to avoid misinterpretation during prostate cancer staging. This evidence concerns the gene FOLH1 and prostate neoplasm.